Bal Pharma Limited (BALPHARMA.NS) NSE

73.79

-0.04(-0.05%)

Updated at December 24 03:26PM

Currency In INR

Valuation

Market Cap1.31B
Enterprise Value2.73B
P/E Ratio16.94
PEG Ratio-4.1
Price/Sales Ratio0.4
Price/Book Ratio1.48
Enterprise/Revenue0.92
Enterprise/EBITDA8.82

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.02
Operating Margin0.06

Management Effectiveness

Return On Assets0.02
Return On Equity0.09

Income Statement

Revenue3.03B
Revenue/Share187.06
Gross Profit730.19M
EBITDA317.63M
Net Income72.15M
Diluted EPS4.56

Balance Sheet

Total Cash106.56M
Total Cash/Share6.76
Total Debt1.55B
Total Debt/Equity1.98
Current Ratio1.07
Book Value Per Share49.68

Price History

52-Week Change-40.35
52-Week High132
52-Week Low70.05
Moving Average 50 Days77.91
Moving Average 200 Days90.82

Statistics

Average Volume11,996
Shares Outstanding15.92M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate1.2
Trailing Annual Dividend Yield1.64
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A